QTc interval prolongation by d-propoxyphene: what about other analgesics?

Expert Opinion on Pharmacotherapy
Robert B RaffaJoseph V Pergolizzi

Abstract

d-Propoxyphene, which was previously available in many single-agent and combination products, was recently voluntarily withdrawn from the US market following an FDA recommendation based partly on the concern that the risk associated with QT prolongation exceeded the clinical benefit of the drug. The drug had previously been withdrawn from European markets. These recent actions prompt the question: what is known about QT prolongation and analgesic drugs? A systematic search was conducted of 50 opioid and non-opioid analgesic drugs using PubMed, the FDA website, and the Internet. Search terms for opioids, NSAIDs, acetaminophen and other analgesics were used (including both generic and brand names), along with QTc, QTc prolongation, QTc interval, hERG, torsades de pointes (TdP), ventricular arrhythmias, and other relevant terms. There is a paucity of available information on the QT interval for most analgesics. Of those for which there is a lot of data, only methadone, oxycodone, and LAAM (levo--acetylmethadol) appear to have a known and accepted level of effect on the QT interval.

References

Oct 1, 1976·Biomedical Mass Spectrometry·S L DueR E McMahon
Sep 15, 1992·The American Journal of Cardiology·A SagieD Levy
Jul 1, 1989·British Journal of Pharmacology·G Boachie-AnsahJ R Parratt
Aug 1, 1982·British Journal of Pharmacology·O FagbemiL Szekeres
Mar 1, 1994·British Journal of Clinical Pharmacology·K G OldroydS M Cobbe
Dec 1, 1995·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J P ChvilicekG E Hill
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·H A SpillerD L Anderson
Jul 24, 1998·Journal of Cardiovascular Pharmacology·W X WangR L Woosley
May 24, 2000·Journal of Clinical Pathology·C M Milroy, A R Forrest
Feb 22, 2001·Forensic Science International : Synergy·F Musshoff, B Madea
Oct 19, 2001·Basic Research in Cardiology·G F Merrill, E Goldberg
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Sean EkinsSteven A Wrighton
Jun 28, 2002·The Annals of Pharmacotherapy·Atul PathakJean Louis Montastruc
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Alexander N KatchmanSteven N Ebert
Oct 7, 2003·Pain·Craig A KornickPaolo L Manfredi
Nov 19, 2003·American Journal of Therapeutics·Luigi X Cubeddu
Mar 5, 2004·The New England Journal of Medicine·Dan M Roden
Jan 1, 1997·European Journal of Pain : EJP·V SrinivasanI R Tebbett
Feb 18, 2005·Epilepsy Research·Bengt R DanielssonTorbjörn Tomson
Apr 22, 2005·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Abdullah DoganMustafa Ozturk
May 27, 2005·Pharmacoepidemiology and Drug Safety·Ellen C Pearson, Raymond L Woosley
Mar 2, 2006·The Annals of Pharmacotherapy·Jennifer R BakerElinore F McCance-Katz
Apr 1, 2006·International Journal of Cardiology·Konstantinos LetsasFotis Kardaras
Feb 15, 2007·British Journal of Clinical Pharmacology·C HowellW S Waring
Apr 3, 2007·Human Psychopharmacology·Patrick MbayaDavid Bennett
Jun 2, 2007·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Hyoung-Chan ChoYoung-Kyun Chung
Sep 27, 2007·Experimental Biology and Medicine·Gary F MerrillTyler H Rork
Dec 12, 2007·Archives of Internal Medicine·Erich F WedamMark C P Haigney

❮ Previous
Next ❯

Citations

Sep 23, 2014·Current Medical Research and Opinion·Charles E Argoff, Ernest A Kopecky
Aug 27, 2015·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Thien C PhamRobert B Raffa
Sep 16, 2015·Journal of the American Academy of Dermatology·Monica EnamandramAlexandra B Kimball
Jul 10, 2012·Expert Opinion on Pharmacotherapy·Joseph L Schuller, Mori J Krantz
Dec 30, 2014·ACS Chemical Neuroscience·Roberta GualdaniCristina Nativi
Mar 30, 2013·Journal of Pharmacological and Toxicological Methods·David Rampe, Arthur M Brown
Oct 1, 2013·Pharmacological Reviews·Gavril W Pasternak, Ying-Xian Pan
Jan 10, 2018·Medicinal Research Reviews·Přemysl MladěnkaUNKNOWN TOX-OER and CARDIOTOX Hradec Králové Researchers and Collaborators
Nov 21, 2020·Journal of Addictive Diseases·Bahadir DemirAbdurrahman Altindag
Aug 23, 2021·Toxicology and Applied Pharmacology·Sung-Ae HyunMinhan Ka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.